Compound heterozygous mutations (p.Leu13Pro and p.Tyr294*) associated with factor VII deficiency cause impaired secretion through ineffective translocation and extensive intracellular degradation of factor VII.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Thrombosis Research

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.thromres.2012.10.005PMID 23141848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency

  2012cited by this paper
• Molecular Mechanism of Co‐translational Protein Targeting by the Signal Recognition Particle

  2011cited by this paper
• Factor VII Deficiency due to Compound Heterozygosity for Leu-48Pro Mutation and a Novel Pro260Leu Mutation

  2011influential reference
• Impaired secretion of carboxyl-terminal truncated factor VII due to an F7 nonsense mutation associated with FVII deficiency.

  2010cited by this paper
• Factor XII Ofunato: Lys346Asn mutation associated with blood coagulation factor XII deficiency causes impaired secretion through a proteasome-mediated degradation.

  2010cited by this paper
• COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers‐Danlos syndrome

  2009cited by this paper
• Factor VII Deficiency

  2009cited by this paper
• Factor VII deficiency: defining the clinical picture and optimizing therapeutic options

  2008cited by this paper
• The mutation in Japanese congenital factor VII deficiency

  2008cited by this paper
• All post-translational modifications except propeptide cleavage are required for optimal secretion of coagulation factor VII

  2007cited by this paper
• Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis

  2007cited by this paper
• Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease

  2006cited by this paper
• Intracellular Evaluation of ER Targeting Elucidates a Mild Form of Inherited Coagulation Deficiency

  2006cited by this paper
• Factor X Shanghai and disruption of translocation to the endoplasmic reticulum.

  2005cited by this paper
• Post‐translational modifications in proteins involved in blood coagulation

  2005cited by this paper
• Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII.

  2005cited by this paper
• Quality control in the endoplasmic reticulum protein factory

  2003cited by this paper
• Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II.

  2003cited by this paper
• Corrigendum: Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion

  2002cited by this paper
• FACTOR VII DEFICIENCY

  2002cited by this paper
• Identification and Characterization of Two Novel Mutations (Q421K and R123P) in Congenital Factor XII Deficiency

  2001cited by this paper
• Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion

  2000cited by this paper
• Factor XII Tenri, a novel cross-reacting material negative factor XII deficiency, occurs through a proteasome-mediated degradation.

  1999cited by this paper
• Impaired cotranslational processing as a mechanism for type I antithrombin deficiency.

  1998cited by this paper
• Factor VII Morioka (FVII L‐26P): a homozygous missense mutation in the signal sequence identified in a patient with factor VII deficiency

  1998cited by this paper
• ER quality control: the cytoplasmic connection.

  1997cited by this paper
• Factor VII Deficiency

  1997cited by this paper
• Inefficient Membrane Targeting, Translocation, and Proteolytic Processing by Signal Peptidase of a Mutant Preproparathyroid Hormone Protein (*)

  1995cited by this paper
• Translocation of proteins across the endoplasmic reticulum

  1993cited by this paper
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

  1988cited by this paper
• Characterization of a cDNA coding for human factor VII.

  1984cited by this paper
• Secretory protein translocation across membranes—the role of the ‘docking protein’

  1982cited by this paper
• Translocation of proteins across the endoplasmic reticulum III. Signal recognition protein (SRP) causes signal sequence-dependent and site- specific arrest of chain elongation that is released by microsomal membranes

  1981cited by this paper
• Prediction of protein antigenic determinants from amino acid sequences.

  1981cited by this paper

• Multiple Neonatal Deaths and Alexander's Disease: A Case Report

  2023cites this paper
• Factor VII Deficiency Due to Compound Heterozygosity for the p.Leu13Pro Mutation and a Novel Mutation in the HNF4 Binding Region (-58G>C) in the F7 Promoter.

  2022cites this paper
• A novel compound heterozygous variant linked to hematuria in a family with hereditary factor VII deficiency

  2021cites this paper
• Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain.

  2018cites this paper